Pregnancy and epilepsy: Update on pregnancy registries

Current Treatment Options in Neurology

Volumn 10, Issue 4, 2008, Pages 246-252

  Krishnamurthy, Kaarkuzhali B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PREGABALIN; VALPROIC ACID;

CLEFT PALATE; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; HYDRATION; MATERNAL AGE; MATERNAL CARE; MATERNAL NUTRITION; MEDICAL DECISION MAKING; MONOTHERAPY; MOTHER FETUS RELATIONSHIP; NEURAL TUBE DEFECT; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT GUIDANCE; PATIENT MONITORING; POSTMARKETING SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; REGISTER; REVIEW; SEIZURE; SLEEP TIME; SOCIAL STATUS; TREATMENT PLANNING; UNITED STATES;

EID: 58649099370     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0027-8     Document Type: Review

References (21)

1. King PB, Lie RT, Irgens LM: Spina bifida and cleft lip among newborns of Norwegian women with epilepsy: Changes related to the use of anticonvulsants. Am J Public Health 86:1454-1456.
2. Kjaer D, Horvath-Puho E, Christensen J, et al.: Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: A case-time-control study. Pharmacoepidemiol Drug Saf 2007, 16:181-188.
3. Wide K, Winbladh B, Kallen B: Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: A nationwide, population-based register study. Acta Paediatr 2004, 93:174-176.
4. Chang TY, Lai CW, Yu HY, et al.: Preliminary descriptive statistics of the Taiwanese Registry of Epilepsy and Pregnancy for the first 2 years. Taiwan J Obstet Gynecol 2007, 46:47-49.
5. Thomas SV, Indrani L, Devi GC, et al.: Pregnancy in women with epilepsy: preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India 2001, 49:60-66.
6. Beghi E, Annegers JF: Pregnancy registries in epilepsy. Epilepsia 2001, 42:1422-1425.
7. Reiff-Eldridge R, Heffner CR, Ephross SA, et al.: Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: A pharmaceutical company commitment. Am J Obstet Gynecol 2000, 182:159-163.
8. Holmes LB, Wyszynski DF, Lieberman E: The AED (antiepileptic drug) pregnancy registry: A 6-year experience. Arch Neurol 2004, 61:673-678.
9. Wyszynski DF, Nambisan M, Surve T, et al.: Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005, 64:961-965.
10. Hernandez-Diaz S, Smith CR, Wyszynski DF, Holmes LB: Risk of major malformations among infants exposed to carbamazepine during pregnancy [abstract]. Birth Defects Res A Clin Mol Teratol 2007, 79:357.
11. Holmes LB, Wyszynski DF, Baldwin EJ, et al.: Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy [abstract]. Birth Defects Res A Clin Mol Teratol 2006, 76:5.
12. Craig JJ, Morrow JI: New antiepileptic drugs. Register of women who take the drugs during pregnancy has been set up [letter]. BMJ 1997, 314:603.
13. Morrow J, Russell A, Guthrie E, et al.: Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006, 77:193-198.
14. EURAP Study Group: Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006, 66:354-360.
15. Cunnington MC, Messenheimer JA: Fourteen year interim results from an international observational study of pregnancy outcomes following exposure to lamotrigine [abstract 3.202]. Epilepsia 2007, 48(Suppl 6):322-323.
16. Cunnington M, Ferber S, Quartey G; International Lamotrigine Pregnancy Registry Scientific Advisory Committee: Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007, 48:1207-1210.
17. Bronstein K, Leppik I, Montouris G, et al.: Keppra (levetiracetam) pregnancy registry [abstract 3.208]. Epilepsia 2007, 48(Suppl 6):325.
18. Hunt S, Craig J, Russell A, et al.: Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006, 67:1876-1879.
19. Vajda FJ, Lander CM, Hitchcock A, et al.: Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences. J Clin Neurosci 2007, 14:611-617.
20. Tomson T, Perucca E, Battino D: Navigating toward fetal and maternal health: The challenge of treating epilepsy in pregnancy. Epilepsia 2004, 45:1171-1175.
21. Practice parameter: Management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia 1998, 39:1226-1231.